Mesa Laboratories Inc (MLAB)

Return on equity (ROE)

		Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net income	US$ in thousands	—	-254,246	930	1,871	3,274
Total stockholders’ equity	US$ in thousands	—	145,393	393,480	393,801	406,227
ROE		—	-174.87%	0.24%	0.48%	0.81%

March 31, 2025 calculation

ROE = Net income ÷ Total stockholders’ equity
= $—K ÷ $—K
= —

Mesa Laboratories Inc's return on equity (ROE) has shown fluctuations over the past few years. The ROE decreased from 0.81% as of March 31, 2021, to 0.48% as of March 31, 2022, reflecting a slight decline in profitability as measured by the return generated for each unit of shareholder's equity. However, as of March 31, 2023, the ROE further dropped to 0.24%, indicating a continued trend of declining profitability.

The most significant change occurred as of March 31, 2024, when the ROE drastically plummeted to -174.87%. This negative ROE suggests that Mesa Laboratories Inc incurred a substantial loss relative to its shareholder's equity during that period, signaling potential financial challenges or a significant one-time expense impacting profitability.

Unfortunately, no ROE data is available for March 31, 2025. Overall, Mesa Laboratories Inc's ROE trend demonstrates a mix of fluctuations and a sharp decline, with a notable negative impact in the analyzed period. Further analysis and insight into the company's financial performance and strategic decisions would be required to fully understand the factors contributing to these ROE fluctuations.